The protection of MSCs from apoptosis in nerve regeneration by TGFβ1 through reducing inflammation and promoting VEGF-dependent angiogenesis

Biomaterials

Volumn 33, Issue 17, 2012, Pages 4277-4287

  Luo, Hailang ^b   Zhang, Yongjie ^a,b   Zhang, Ziqiang ^b   Jin, Yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Engineering Technology Center for Tissue Engineering of Xi'an   (China)

Author keywords

Adipose derived mesenchymal stem cells; Apoptosis; Nerve regeneration; Transforming growth factor 1; Xenogeneic acellular nerve matrix

Indexed keywords

ANGIOGENESIS; APOPTOSIS RATES; CELL CYCLE; FLUORESCENCE LABELING; HOST IMMUNE RESPONSE; IN-VITRO; IN-VIVO; MESENCHYMAL STEM CELL; NERVE INJURIES; NERVE REGENERATION; NEURAL DIFFERENTIATIONS; NEUTRALIZING ANTIBODIES; PROTECTIVE EFFECTS; REGENERATIVE CAPACITY; SCHWANN CELLS; SCIATIC NERVES; TIME COURSE; TRANSFORMING GROWTH FACTORS;

CELL CULTURE; DEFECTS; EXPERIMENTS; GRAFTS; NEURONS; PATHOLOGY; TISSUE;

CELL DEATH;

FLUORESCENT DYE; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS; CONTROLLED STUDY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE; XENOGENEIC ACELLULAR NERVE MATRIX;

ANIMALS; APOPTOSIS; COLLAGEN; CYTOPROTECTION; DOGS; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, SCID; MYELIN SHEATH; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE REGENERATION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SUS SCROFA; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84862818882     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.02.042     Document Type: Article

References (42)

1. Bellamkonda R.V. Peripheral nerve regeneration: an opinion on channels, scaffolds and anisotropy. Biomaterials 2006, 27:3515-3518.
2. Bozkurt A., Deumens R., Beckmann C., Olde Damink L., Schügner F., Heschel I., et al. In vitro cell alignment obtained with a Schwann cell enriched microstructured nerve guide with longitudinal guidance channels. Biomaterials 2009, 30:169-179.
3. Ribeiro-Resende V.T., Koenig B., Nichterwitz S., Oberhoffner S., Schlosshauer B. Strategies for inducing the formation of bands of Büngner in peripheral nerve regeneration. Biomaterials 2009, 30:5251-5259.
4. Zhang Y., Luo H., Zhang Z., Lu Y., Huang X., Yang L., et al. A nerve graft constructed with xenogeneic acellular nerve matrix and autologous adipose-derived mesenchymal stem cells. Biomaterials 2010, 31:5312-5324.
5. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant 1995, 4:415-436.
6. Laschke M.W., Harder Y., Amon M., Martin I., Farhadi J., Ring A., et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006, 12:2093-2104.
7. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants - a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32:6692-6709.
8. Hubbell J.A., Thomas S.N., Swartz M.A. Materials engineering for immunomodulation. Nature 2009, 462:449-460.
9. Seuntjens E., Umans L., Zwijsen A., Sampaolesi M., Verfaillie C.M., Huylebroeck D. Transforming growth factor type beta and smad family signaling in stem cell function. Cytokine Growth Factor Rev 2009, 20:449-458.
10. Kiefer R., Streit W.J., Toyka K.V., Kreutzberg G.W., Hartung H.P. Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system. Int J Dev Neurosci 1995, 13:331-339.
11. Chin J., Liu R.Y., Cleary L.J., Eskin A., Byrne J.H. TGF-beta1-induced long-term changes in neuronal excitability in aplysia sensory neurons depend on MAPK. J Neurophysiol 2006, 95:3286-3290.
12. Rosner B.I., Hang T., Tranquillo R.T. Schwann cell behavior in three-dimensional collagen gels: evidence for differential mechano-transduction and the influence of TGF-beta 1 in morphological polarization and differentiation. Exp Neurol 2005, 195:81-91.
13. Mucida D., Cheroutre H. TGFbeta and retinoic acid intersect in immune-regulation. Cell Adh Migr 2007, 1:142-144.
14. Sánchez-Capelo A. Dual role for TGF-beta1 in apoptosis. Cytokine Growth Factor Rev 2005, 16:15-34.
15. ten Dijke P., Arthur H.M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 2007, 8:857-869.
16. Goumans M.J., Valdimarsdottir G., Itoh S., Lebrin F., Larsson J., Mummery C., et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003, 12:817-828.
17. Liu Z., Kobayashi K., van Dinther M., van Heiningen S.H., Valdimarsdottir G., van Laar T., et al. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. J Cell Sci 2009, 122:3294-3302.
18. Bian Y.Z., Wang Y., Aibaidoula G., Chen G.Q., Wu Q. Evaluation of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) conduits for peripheral nerve regeneration. Biomaterials 2009, 30:217-225.
19. Bhang S.H., Lee T.J., Lim J.M., Lim J.S., Han A.M., Choi C.Y., et al. The effect of the controlled release of nerve growth factor from collagen gel on the efficiency of neural cell culture. Biomaterials 2009, 30:126-132.
20. Salomoni P., Calegari F. Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol 2010, 20:233-243.
21. Crapo P.M., Gilbert T.W., Badylak S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32:3233-3243.
22. Neubauer D., Graham J.B., Muir D. Chondroitinase treatment increases the effective length of acellular nerve grafts. Exp Neurol 2007, 207:163-170.
23. Hudson T.W., Liu S.Y., Schmidt C.E. Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng 2004, 10:1346-1358.
24. Madison R.D., Archibald S.J., Lacin R., Krarup C. Factors contributing to preferential motor reinnervation in the primate peripheral nervous system. J Neurosci 1999, 19:11007-11016.
25. Wang X., Hu W., Cao Y., Yao J., Wu J., Gu X. Dog sciatic nerve regeneration across a 30-mm defect bridged by a chitosan/PGA artificial nerve graft. Brain 2005, 128:1897-1910.
26. Suzuki Y., Tanihara M., Ohnishi K., Suzuki K., Endo K., Nishimura Y. Cat peripheral nerve regeneration across 50 mm gap repaired with a novel nerve guide composed of freeze-dried alginate gel. Neurosci Lett 1999, 259:75-78.
27. Höke A. Mechanisms of disease: what factors limit the success of peripheral nerve regeneration in humans?. Nat Clin Pract Neurol 2006, 2:448-454.
28. Matsumoto K., Ohnishi K., Kiyotani T., Sekine T., Ueda H., Nakamura T., et al. Peripheral nerve regeneration across an 80-mm gap bridged by a polyglycolic acid (PGA)-collagen tube filled with laminin-coated collagen fibers: a histological and electrophysiological evaluation of regenerated nerves. Brain Res 2000, 868:315-328.
29. Zhu Y., Yang G.Y., Ahlemeyer B., Pang L., Che X.M., Culmsee C., et al. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 2002, 22:3898-3909.
30. Gister B., Delrée P., Leprince P., Martin D., Sadzot C., Malgrange B., et al. Transforming growth factor beta as a neuronoglial signal during peripheral nervous system response to injury. J Neurosci Res 1993, 34:32-43.
31. Iwasaki Y., Shiojima T., Tagaya N., Kobayashi T., Kinoshita M. Effect of transforming growth factor beta 1 on spinal motor neurons after axotomy. J Neurol Sci 1997, 147:9-12.
32. Mishra L., Derynck R., Mishra B. Transforming growth factor-beta signaling in stem cells and cancer. Science 2005, 310:68-71.
33. Chen Z.L., Yu W.M., Strickland S. Peripheral regeneration. Annu Rev Neurosci 2007, 30:209-233.
34. Makwana M., Raivich G. Molecular mechanisms in successful peripheral regeneration. FEBS J 2005, 272:2628-2638.
35. Hobson M.I., Green C.J., Terenghi G. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat 2000, 197:591-605.
36. Ribeiro-Resende V.T., Pimentel-Coelho P.M., Mesentier-Louro L.A., Mendez R.M., Mello-Silva J.P., Cabral-da-Silva M.C., et al. Trophic activity derived from bone marrow mononuclear cells increases peripheral nerve regeneration by acting on both neuronal and glial cell populations. Neuroscience 2009, 159:540-549.
37. Cai L., Johnstone B.H., Cook T.G., Tan J., Fishbein M.C., Chen P.S., et al. Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 2009, 27:230-237.
38. Guo X., Du J., Zheng Q., Liu Y., Duan D., Wu Y. Molecular tissue engineering: applications for modulation of mesenchymal stem cells proliferation by transforming growth factor beta 1 gene transfer. J Tongji Med Univ 2001, 21:314-317.
39. Lu X., Richardson P.M. Inflammation near the nerve cell body enhances axonal regeneration. J Neurosci 1991, 11:972-978.
40. Hotchkiss R.S., Nicholson D.W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006, 6:813-822.
41. Bayrak A., Tyralla M., Ladhoff J., Schleicher M., Stock U.A., Volk H.D., et al. Human immune responses to porcine xenogeneic matrices and their extracellular matrix constituents in vitro. Biomaterials 2010, 31:3793-3803.
42. Yang L. TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy. Curr Mol Med 2010, 10:374-380.